Targeted Therapy at the End of Life in Advanced Cancer Patients
- 1 September 2012
- journal article
- research article
- Published by Mary Ann Liebert Inc in Journal of Palliative Medicine
- Vol. 15 (9), 991-997
- https://doi.org/10.1089/jpm.2012.0050
Abstract
Objective: We describe the use of systemic therapy in advanced cancer patients admitted to an acute care hospital, with a focus on targeted therapy. We aim to spotlight the utilization of targeted agents in the last months of life. Methods: Adult patients (N=252) with advanced solid tumors who died as inpatients in the National University Hospital, Singapore, were included in this retrospective study. Patients' demographic and clinical data were extracted from hospital records. Information on systemic therapy was extracted from the time of diagnosis and all other data limited to the last three months before death. Results: 187 adult patients received palliative systemic therapy from the time of diagnosis, of which 125 (66.8%) received it within three months of death. Of patients receiving only nontargeted systemic treatment (n=106), 60 (56.6%) and 26 (24.5%) received it within three months and one month of death respectively. Comparatively, 81 patients received palliative targeted systemic therapy, of which 65 (80.3%) and 40 (49.4%) had treatment within three months and one month of death respectively (p=0.001 and ppConclusions: Targeted therapy is used in more than half of patients who received systemic therapy within three months of death. The degree to which these agents are being utilized near the end of life suggests the need to reexamine the risk/benefit profile of targeted therapy for this population, and the decision-making process around their use.Keywords
This publication has 39 references indexed in Scilit:
- Palliative chemotherapy during the last month of lifeAnnals of Oncology, 2011
- Place of Death and Its Determinants for Patients with Cancer in Singapore: An Analysis of Data from the Singapore Cancer Registry, 2000–2009Journal of Palliative Medicine, 2011
- Trends in the Aggressiveness of End-of-Life Cancer Care in the Universal Health Care System of Ontario, CanadaJournal of Clinical Oncology, 2011
- Targeted Therapy at the End of Life for Patients with Lung CancerJournal of Palliative Medicine, 2010
- Aggressiveness of Cancer Care Near the End of Life: Is It a Quality-of-Care Issue?Journal of Clinical Oncology, 2008
- Chemotherapy Use and Associated Factors among Cancer Patients near the End of LifeOncology, 2007
- The aggressiveness of cancer care in the last three months of life: a retrospective single centre analysisPsycho‐Oncology, 2007
- Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast CancerThe New England Journal of Medicine, 2005
- What Is Targeted Therapy?Journal of Clinical Oncology, 2005
- CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell LymphomaThe New England Journal of Medicine, 2002